| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-14 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-14 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-12 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-12 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-12 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-12 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-12 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-11 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-11 |